Pathological and clinical correlations in primary cutaneous B-cell lymphomas: A series of 44 cases;Lymphomes B cutanés primitifs: Corrélations anatomo-cliniques dans une série de 44 cas

Annales de Pathologie

Volumn 25, Issue 1, 2005, Pages 8-17

  De La Fouchardière, Arnaud ^a,f   Balme, Brigitte ^b   Chouvet, Brigitte ^c   Perrot, Henri ^d   Thomas, Luc ^b   Claudy, Alain ^c   Felman, Pascale ^e,f   Salles, Gilles ^e,f   Coiffier, Bertrand ^e,f   Berger, Françoise ^e,f  

^a CROIX ROUSSE HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d Hopital de l'Antiquaille   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

B cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Marginal zone lymphoma; Skin

Indexed keywords

ADULT; AGE; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RELAPSE; CANCER THERAPY; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CUTANEOUS B CELL LYMPHOMA; DIFFUSE LARGE B CELL LYMPHOMA; EXTRACUTANEOUS LYMPHOMA; FATALITY; FEMALE; FOLLICULAR LYMPHOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; MARGINAL ZONE B CELL LYMPHOMA; MOLECULAR ANALYSIS; MOLECULAR BIOLOGY; OUTCOMES RESEARCH; PATHOLOGY; PHENOTYPE; PRIMARY CUTANEOUS B CELL LYMPHOMA; PROGNOSIS; RARE DISEASE; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

EID: 20144389823     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(05)80094-x     Document Type: Article

References (33)

1. Willemze R, Meijer CJ. EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer. Am J Dermatopathol 1999; 21: 265-73.
2. Slater DN. Is the WHO classification suitable for skin lymphoma? Histopathology 2000; 37: 282-3.
3. Kerl H, Cerroni L. Controversies in cutaneous lymphomas. Semin Cutan Med Surg 2000; 19: 157-60.
4. Sander CA, Flaig MJ, Kaudewitz P, Jaffe ES. The revised European-American Classification of Lymphoid Neoplasms (REAL): a preferred approach for the classification of cutaneous lymphomas. Am J Dermatopathol 1999; 21: 274-8.
5. Jaffe E, Harris NL, Stein H, Vardiman J (Eds): WHO classification. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001
6. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-71.
7. Vermeer MH, Geelen FA, van Haselen CW, Voorst Vader PC, Geerts ML, van Vloten WA et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol 1996; 132: 1304-8.
8. de la Fouchardière A, Balme B, Chouvet B, Sebban C, Perrot H, Claudy A et al. Primary cutaneous marginal zone B-cell lymphoma: a report of 9 cases. J Am Acad Dermatol 1999; 41: 181-8.
9. Aubin J, Davi F, Nguyen-Salomon F, Leboeuf D, Debert C, Taher M et al. Description of a novel FRI IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 1995; 9: 471-9.
10. Colombat P, Salles G, Brousse N, Eftekhari P, Soubeyran P, Delwail V et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood 2001; 97: 101-6.
11. Baldassano MF, Bailey EM, Ferry JA, Harris NL, Duncan LM. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol 1999; 23: 88-96.
12. Servitje O, Gallardo F, Estrach T, Pujol RM, Blanco A, Fernandez-Sevilla A et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol 2002; 147: 1147-58.
13. Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457-61.
14. Goodlad JR, Davidson MM, Hollowood K, Batstone P, Ho-Yen DO. Borrelia burgdorferi-associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi-associated B-cell proliferation in the skin. Histopathology 2000; 37: 501-8.
15. Wood GS, Kamath NV, Guitart J, Heald P, Kohler S, Smoller BR et al. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol 2001; 28: 502-7.
16. Li C, Inagaki H, Kuo TT, Hu S, Okabe M, Eimoto T. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases. Am J Surg Pathol 2003; 27: 1061-9.
17. de la Fouchardière A, Vandenesch F, Berger F. Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region. Am J Surg Pathol 2003; 27: 702-3.
18. Bailey EM, Ferry JA, Harris NL, Mihm MC Jr, Jacobson JO, Duncan LM. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol 1996; 20: 1011-23.
19. Sangueza OP, Burket JM, Sacks Y. Primary cutaneous immunocytoma: report of an unusual case with secondary spreading to the gastrointestinal tract. J Cutan Pathol 1997; 24: 43-6.
20. Grange F, Bekkenk MW, Wechsler J, Meijer CJ, Cerroni L, Bernengo M et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol 2001; 19: 3602-10.
21. Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer 1991; 67: 2311-26.
22. Gronbaek K, Moller PH, Nedergaard T, Thomsen K, Baadsgaard O, Hou-Jensen K et al. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases. Br J Dermatol 2000; 142: 913-23.
23. Willemze R. New concepts in the classification of cutaneous lymphomas. Arch Dermatol 1995; 131: 1077-80.
24. Fernandez-Vazquez A, Rodriguez-Peralto JL, Martinez MA, Platon EM, Algara P, Camacho FI et al. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival. Am J Surg Pathol 2001; 25: 307-15.
25. Franco R, Fernandez-Vazquez A, Rodriguez-Peralto JL, Bellas C, Lopez-Rios F, Saez A et al. Cutaneous follicular B-cell lymphoma: description of a series of 18 cases. Am J Surg Pathol 2001; 25: 875-83.
26. Cerroni L, Arzberger E, Putz B, Hofler G, Metze D, Sander CA et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 2000; 95: 3922-8.
27. De Levai L, Harris NL, Longtine J, Ferry JA, Duncan LM. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2. and CD21 in differential diagnosis and classification. Am J Surg Pathol 2001; 25: 732-41.
28. Yang B, Tubbs RR, Finn W, Carlson A, Pettay J, Hsi ED. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. Am J Surg Pathol 2000; 24: 694-702.
29. Aguilera NS, Tomaszewski MM, Moad JC, Bauer FA, Taubenberger JK, Abbondanzo SL. Cutaneous follicle center lymphoma: a clinicopathologic study of 19 cases. Mod Pathol 2001; 14: 828-35.
30. Child FJ, Russell-Jones R, Woolford AJ, Calonje E, Photiou A, Orchard G et al. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. Br J Dermatol 2001; 144: 735-44.
31. Child FJ, Russell-Jones R, Calonje E, Whittaker SJ. Molecular genetic characterization of primary cutaneous B-cell lymphomas. Am J Surg Pathol 2001; 25: 538-9.
32. Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G et al. T(14;18)(q32;q21) involving IGH and MALTI is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101: 2335-9.
33. Cook JR, Sherer M, Craig FE, Shekhter-Levin S, Swerdlow SH. T(14;18)(q32;q21) involving MALTI and IGH genes in an extranodal diffuse large B-cell lymphoma. Hum Pathol 2003; 34: 1212-5.